• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lessons learned from the PMTCT program in Swaziland: challenges with accepting lifelong ART for pregnant and lactating women - a qualitative study.从斯威士兰预防母婴传播项目中吸取的经验教训:接受孕妇和哺乳期妇女终身抗逆转录病毒治疗面临的挑战——一项定性研究
BMC Public Health. 2016 Oct 24;16(1):1119. doi: 10.1186/s12889-016-3767-5.
2
Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.津巴布韦部分医疗机构中HIV阳性孕妇和哺乳期妇女对终身治疗(选项B+)的接受度:一项定性研究
BMC Public Health. 2017 Jul 25;18(1):57. doi: 10.1186/s12889-017-4611-2.
3
HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.马拉维艾滋病毒呈阳性的孕妇和产后妇女对“B+方案”的看法:一项定性研究
J Int AIDS Soc. 2016 Jun 15;19(1):20919. doi: 10.7448/IAS.19.1.20919. eCollection 2016.
4
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
5
Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.了解印度尼西亚巴布亚地区妇女对 B+方案的接受和坚持情况,以预防母婴传播艾滋病毒:一项定性研究。
PLoS One. 2018 Jun 18;13(6):e0198329. doi: 10.1371/journal.pone.0198329. eCollection 2018.
6
Acceptability and challenges of rapid ART initiation among pregnant women in a pilot programme, Cape Town, South Africa.南非开普敦一项试点项目中孕妇快速启动抗逆转录病毒治疗的可接受性与挑战
AIDS Care. 2014;26(6):736-41. doi: 10.1080/09540121.2013.855300. Epub 2013 Nov 7.
7
Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.斯威士兰所有 HIV 阳性孕妇和哺乳期妇女普遍启动终身抗逆转录病毒治疗的成本及成本效益。
Trop Med Int Health. 2018 Sep;23(9):950-959. doi: 10.1111/tmi.13121. Epub 2018 Jul 26.
8
Exploring the acceptability of Option B plus among HIV-positive Nigerian women engaged and not engaged in the prevention of mother-to-child transmission of HIV cascade: a qualitative study.探索“B 方案加强版”在参与和未参与预防艾滋病毒母婴传播服务流程的尼日利亚艾滋病毒阳性女性中的可接受性:一项定性研究。
SAHARA J. 2018 Dec;15(1):128-137. doi: 10.1080/17290376.2018.1527245.
9
Deterrents to Immediate Antiretroviral Therapy Initiation by Pregnant Women Living with HIV in Hhohho Region, Swaziland.斯威士兰霍霍地区感染艾滋病毒的孕妇立即开始抗逆转录病毒治疗的阻碍因素。
Afr J Reprod Health. 2018 Dec;22(4):72-80. doi: 10.29063/ajrh2018/v22i4.8.
10
Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa.针对感染艾滋病毒的孕妇的社区支持的有效性:南非的一项队列研究。
AIDS Care. 2016;28 Suppl 1(sup1):114-8. doi: 10.1080/09540121.2016.1148112. Epub 2016 Feb 28.

引用本文的文献

1
Womandla Health: development and rationale of a behavioral intervention to support HIV treatment adherence among postpartum women in South Africa.妇女与健康组织:支持南非产后妇女坚持接受艾滋病毒治疗的行为干预措施的制定和基本原理。
BMC Womens Health. 2023 Dec 6;23(1):649. doi: 10.1186/s12905-023-02817-y.
2
A Peer-support Mini-counseling Model to Improve Treatment in HIV-positive Pregnant Women in Kupang City, East Nusa Tenggara, Indonesia.印度尼西亚东努沙登加拉省古邦市的一项基于同伴支持的迷你咨询模式,旨在改善 HIV 阳性孕妇的治疗效果。
J Prev Med Public Health. 2023 May;56(3):238-247. doi: 10.3961/jpmph.22.516. Epub 2023 Apr 11.
3
Knowledge and Perceptions of Healthcare Workers about the Implementation of the Universal Test and Treat Guideline in Under-Resourced, High-HIV Prevalence Rural Settings.医疗工作者对资源匮乏、艾滋病毒高流行率农村地区实施普遍检测与治疗指南的认知与看法。
Healthcare (Basel). 2023 Mar 28;11(7):968. doi: 10.3390/healthcare11070968.
4
HIV Positive Pregnant Mothers' Perceptions and Experiences Regarding the Prevention of Mother-to-Child Transmission, Option B+ Program.感染艾滋病毒的孕妇对预防母婴传播(B+方案)的认知与经历
J Patient Exp. 2021 Dec 6;8:23743735211065272. doi: 10.1177/23743735211065272. eCollection 2021.
5
How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda-A qualitative study.在卢旺达的“全面治疗”中,何时启动抗逆转录病毒治疗(ART)过早?以及在参与艾滋病毒护理方面的挑战:一项定性研究。
PLoS One. 2021 May 13;16(5):e0251645. doi: 10.1371/journal.pone.0251645. eCollection 2021.
6
Understanding the influence of health systems on women's experiences of Option B+: A meta-ethnography of qualitative research from sub-Saharan Africa.理解卫生系统对妇女选择 B+方案体验的影响:来自撒哈拉以南非洲的定性研究的元民族志。
Glob Public Health. 2021 Feb;16(2):167-185. doi: 10.1080/17441692.2020.1851385. Epub 2020 Dec 7.
7
Outcomes After Being Lost to Follow-up Differ for Pregnant and Postpartum Women When Compared With the General HIV Treatment Population in Rural South Africa.在南非农村,与一般 HIV 治疗人群相比,失访的孕妇和产后妇女的结局不同。
J Acquir Immune Defic Syndr. 2020 Oct 1;85(2):127-137. doi: 10.1097/QAI.0000000000002413.
8
Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project.在乌干达权力下放后,抗逆转录病毒方案中的检测和治疗经验教训:Lablite 项目内公共保健机构内结果的回顾性分析。
Int Health. 2020 Sep 1;12(5):429-443. doi: 10.1093/inthealth/ihz090.
9
Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in IMPAACT PROMISE Studies Across the Globe.全球 IMPAACT PROMISE 研究中纳入的母亲对普遍使用抗逆转录病毒疗法(ART)的接受速度缓慢。
AIDS Behav. 2019 Sep;23(9):2522-2531. doi: 10.1007/s10461-019-02624-3.
10
Examining engagement in care of women living with HIV in South India.检查在印度南部生活的 HIV 感染者女性参与护理的情况。
Health Care Women Int. 2020 May;41(5):553-566. doi: 10.1080/07399332.2019.1623799. Epub 2019 Jun 26.

本文引用的文献

1
Barriers to initiating antiretroviral therapy during pregnancy: a qualitative study of women attending services in Cape Town, South Africa.孕期开始抗逆转录病毒治疗的障碍:对南非开普敦接受服务的女性进行的定性研究。
Afr J AIDS Res. 2012 Mar;11(1):65-73. doi: 10.2989/16085906.2012.671263.
2
Community approaches to preventing mother-to-child HIV transmission: perspectives from rural Lesotho.预防母婴传播艾滋病毒的社区方法:莱索托农村地区的观点
Afr J AIDS Res. 2008 Jul;7(2):219-28. doi: 10.2989/AJAR.2008.7.2.7.524.
3
Implementation and Operational Research: Barriers and Facilitators to Combined ART Initiation in Pregnant Women With HIV: Lessons Learnt From a PMTCT B+ Pilot Program in Swaziland.实施与运营研究:艾滋病毒感染孕妇联合抗逆转录病毒治疗启动的障碍与促进因素:从斯威士兰预防母婴传播B+试点项目中汲取的经验教训
J Acquir Immune Defic Syndr. 2015 May 1;69(1):e24-30. doi: 10.1097/QAI.0000000000000537.
4
Lessons learned from early implementation of option B+: the Elizabeth Glaser Pediatric AIDS Foundation experience in 11 African countries.从早期实施选项 B+中吸取的经验教训:伊丽莎白·格拉泽儿科艾滋病基金会在 11 个非洲国家的经验。
J Acquir Immune Defic Syndr. 2014 Dec 1;67 Suppl 4(Suppl 4):S188-94. doi: 10.1097/QAI.0000000000000372.
5
A qualitative analysis of the barriers and facilitators to receiving care in a prevention of mother-to-child program in Nkhoma, Malawi.对马拉维恩科马预防母婴传播项目中接受护理的障碍和促进因素的定性分析。
Afr J Reprod Health. 2013 Dec;17(4 Spec No):118-29.
6
Male involvement for the prevention of mother-to-child HIV transmission: A brief review of initiatives in East, West, and Central Africa.男性参与预防母婴传播艾滋病毒:对东非、西非和中非相关举措的简要回顾。
Curr HIV/AIDS Rep. 2014 Jun;11(2):109-18. doi: 10.1007/s11904-014-0200-5.
7
Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi. Malawi 实施针对 HIV 感染孕妇和哺乳期妇女的普遍抗逆转录病毒治疗(“B+方案”)的患者保持治疗情况。
AIDS. 2014 Feb 20;28(4):589-598. doi: 10.1097/QAD.0000000000000143.
8
'If I am given antiretrovirals I will think I am nearing the grave': Kenyan HIV serodiscordant couples' attitudes regarding early initiation of antiretroviral therapy.“如果给我抗逆转录病毒药物,我会觉得自己快死了”:肯尼亚艾滋病毒血清学不一致夫妇对抗逆转录病毒疗法早期启动的态度。
AIDS. 2014 Jan 14;28(2):227-33. doi: 10.1097/QAD.0000000000000025.
9
Acceptability and challenges of rapid ART initiation among pregnant women in a pilot programme, Cape Town, South Africa.南非开普敦一项试点项目中孕妇快速启动抗逆转录病毒治疗的可接受性与挑战
AIDS Care. 2014;26(6):736-41. doi: 10.1080/09540121.2013.855300. Epub 2013 Nov 7.
10
Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review.撒哈拉以南非洲地区抗逆转录病毒药物用于预防母婴传播的采用障碍和促进因素:系统评价。
J Int AIDS Soc. 2013 Jul 19;16(1):18588. doi: 10.7448/IAS.16.1.18588.

从斯威士兰预防母婴传播项目中吸取的经验教训:接受孕妇和哺乳期妇女终身抗逆转录病毒治疗面临的挑战——一项定性研究

Lessons learned from the PMTCT program in Swaziland: challenges with accepting lifelong ART for pregnant and lactating women - a qualitative study.

作者信息

Katirayi Leila, Chouraya Caspian, Kudiabor Kwashie, Mahdi Mohammed Ali, Kieffer Mary Pat, Moland Karen Marie, Tylleskar Thorkild

机构信息

Elizabeth Glaser Pediatric AIDS Foundation, 1140 Connecticut Ave NW, Suite 200, Washington DC, 20036, USA.

Center for International Health, University of Bergen, Bergen, Norway.

出版信息

BMC Public Health. 2016 Oct 24;16(1):1119. doi: 10.1186/s12889-016-3767-5.

DOI:10.1186/s12889-016-3767-5
PMID:27776495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5078916/
Abstract

BACKGROUND

Swaziland has one of the highest HIV prevalence rates in sub-Saharan Africa, 26 % of the adult population is infected with HIV. The prevalence is highest among pregnant women, at 41.1 %. According to Swaziland's prevention of mother-to-child transmission (PMTCT) guidelines, approximately 50 % of pregnant women are eligible for antiretroviral therapy (ART) by CD4 criteria (<350 cells/ml). Studies have shown that most mother-to-child transmission and postnatal deaths occur among women who are eligible for ART. Therefore, ensuring that ART eligible women are initiated on ART is critical for PMTCT and for mother and baby survival. This study provides insight into the challenges of lifelong ART initiation among pregnant women under Option A in Swaziland. We believe that these challenges and lessons learned from initiating women on lifelong ART under Option A are relevant and important to consider during implementation of Option B+.

METHODS

HIV-positive, treatment-eligible, postpartum women and nurses were recruited within maternal and child health (MCH) units using convenience and purposive sampling. Participants came from both urban and rural areas. Focus group discussions (FGDs) and structured interviews using a short answer questionnaire were conducted to gain an understanding of the challenges experienced when initiating lifelong ART. Seven FGDs (of 5-11 participants) were conducted, four FGDs with nurses, two FGDs with women who initiated ART, and one FGD with women who did not initiate ART. A total of 83 interviews were conducted; 50 with women who initiated ART and 33 with women who did not initiate. Data collection with the women was conducted in the local language of SiSwati and data collection with the nurses was done in English. FGDs were audio-recorded and simultaneously transcribed and translated into English. Analysis was conducted using thematic analysis. Transcripts were coded by two researchers in the qualitative software program MAXqda v.10. Thematic findings were illustrated using verbatim quotes which were selected on the basis of being representative of a specific theme. The short-answer interview questionnaire included specific questions about the different steps in the woman's experience initiating ART; therefore the responses for each question were analyzed separately.

RESULTS

Findings from the study highlight women feeling overwhelmed by the lifetime commitment of ART, feeling "healthy" when asked to initiate ART, preference for short-course prophylaxis and fear of side effects (body changes). Also, the preference for nurses to determine on an individual basis the number of counseling appointments a woman needs before initiating ART, more information about HIV and ART needed at the community level, and the need to educate men about HIV and ART.

CONCLUSION

Women face a myriad of challenges initiating lifelong ART. Understanding women's concerns will aid in developing effective counseling messages, designing appropriate counseling structures, understanding where additional support is needed in the process of initiating ART, and knowing who to target for community level messages.

摘要

背景

斯威士兰是撒哈拉以南非洲地区艾滋病毒感染率最高的国家之一,26%的成年人口感染了艾滋病毒。孕妇中的感染率最高,为41.1%。根据斯威士兰的预防母婴传播(PMTCT)指南,约50%的孕妇符合通过CD4标准(<350个细胞/毫升)接受抗逆转录病毒治疗(ART)的条件。研究表明,大多数母婴传播和产后死亡发生在符合ART治疗条件的妇女中。因此,确保符合ART治疗条件的妇女开始接受ART治疗对于预防母婴传播以及母婴存活至关重要。本研究深入探讨了斯威士兰在A方案下孕妇开始终身ART治疗所面临的挑战。我们认为,这些挑战以及从A方案下让妇女开始终身ART治疗中吸取的经验教训,在实施B+方案时值得考虑且具有重要意义。

方法

在妇幼保健(MCH)单位采用便利抽样和目的抽样的方法招募了HIV阳性、符合治疗条件的产后妇女和护士。参与者来自城市和农村地区。通过焦点小组讨论(FGD)和使用简短回答问卷的结构化访谈,以了解开始终身ART治疗时所经历的挑战。共进行了7次FGD(每次5 - 11名参与者),其中4次与护士进行,2次与开始接受ART治疗的妇女进行,1次与未开始接受ART治疗的妇女进行。总共进行了83次访谈;50次与开始接受ART治疗的妇女进行,33次与未开始接受ART治疗的妇女进行。与妇女的数据收集使用当地语言斯瓦蒂语,与护士的数据收集使用英语。FGD进行了录音,并同时转录和翻译成英语。采用主题分析进行分析。两位研究人员在定性软件程序MAXqda v.10中对转录本进行编码。使用逐字引用来说明主题发现,这些引用是根据代表特定主题而选择的。简短回答访谈问卷包括关于妇女开始ART治疗经历中不同步骤的具体问题;因此,对每个问题的回答分别进行分析。

结果

该研究的结果突出表明,妇女对ART治疗的终身承诺感到不堪重负,在被要求开始ART治疗时感觉“健康”,倾向于短期预防用药以及对副作用(身体变化)感到恐惧。此外,倾向于由护士根据个人情况确定妇女在开始ART治疗前所需的咨询预约次数,社区层面需要更多关于艾滋病毒和ART的信息,以及需要对男性进行艾滋病毒和ART教育。

结论

妇女在开始终身ART治疗时面临众多挑战。了解妇女的担忧将有助于制定有效的咨询信息、设计适当的咨询结构、了解在开始ART治疗过程中何处需要额外支持,以及知道在社区层面信息应针对哪些人群。